Finance ❯ Investments ❯ Stock Market ❯ Securities

Class Action Lawsuits

Law Firms Urge Corcept Investors To Seek Lead Role In Securities Case Before April 21

The suit claims the company hid FDA concerns about relacorilant’s trial evidence.

Vistagen Faces Federal Securities Class Action After Fasedienol Phase 3 Failure

Law Firms Court Gauzy Investors for Lead Role in Securities Suit as Feb. 6 Deadline Nears

James Hardie Investors Face Lead‑Plaintiff Deadline Today in Securities Class Action

Synopsys Investors Face Dec. 30 Lead-Plaintiff Deadline in Securities Class Action

Freeport-McMoRan Investors Get Jan. 12 Deadline in Arizona Securities Case Tied to Grasberg Safety Claims

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

KBR Investors Face Nov. 18 Deadline to Seek Lead Role in Securities Suit Over HomeSafe Disclosures

Investor Firms Press Baxter Securities Case Over Novum Pump as Dec. 15 Lead-Plaintiff Deadline Nears

Quanex Faces Securities Class Action Over Tyman Mexico Disclosures as Lead‑Plaintiff Deadline Nears

KBR Securities Suits Intensify as Firms Urge Investors to Meet Nov. 18 Lead‑Plaintiff Deadline

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action